Successful treatment of subacute lupus erythematosus with ustekinumab

Arch Dermatol. 2011 Aug;147(8):896-8. doi: 10.1001/archdermatol.2011.185.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Lupus Erythematosus, Cutaneous / drug therapy*
  • Middle Aged
  • Remission Induction
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ustekinumab